GE HealthCare Technologies Inc. (GEHC) to Distribute Quarterly Dividend of $0.04 on November 13th

Posted by George Bondi on Sep 24th, 2026

GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) announced a quarterly dividend on Tuesday, September 22nd. Stockholders of record on Friday, October 23rd will be given a dividend of 0.04 per share on Friday, November 13th. This represents a c) annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. This is a 14.3% increase from GE HealthCare Technologies’s previous quarterly dividend of $0.04.

GE HealthCare Technologies has a payout ratio of 3.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect GE HealthCare Technologies to earn $5.41 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 2.6%.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $66.09 on Thursday. GE HealthCare Technologies has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92. The firm has a fifty day simple moving average of $68.44 and a 200 day simple moving average of $67.38. The stock has a market capitalization of $29.85 billion, a PE ratio of 15.16, a P/E/G ratio of 1.75 and a beta of 0.70.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. The business had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the company earned $1.06 earnings per share. On average, research analysts expect that GE HealthCare Technologies will post 4.93 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on GEHC shares. Citigroup raised their target price on shares of GE HealthCare Technologies from $69.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, July 30th. Zacks Research upgraded GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 11th. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, July 30th. Evercore restated an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Finally, UBS Group raised their price target on GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Eleven analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $78.39.

Check Out Our Latest Report on GEHC

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies Inc is a global medical technology, pharmaceutical diagnostics and digital solutions company headquartered in Chicago, Illinois. The company provides products and services designed to support healthcare providers across diagnostic imaging, clinical care and treatment planning.

Its portfolio includes imaging systems such as magnetic resonance imaging, computed tomography, molecular imaging, X-ray and surgical imaging equipment. GE HealthCare also offers ultrasound systems, patient monitoring and care solutions, anesthesia delivery and respiratory care products, maternal and infant care technologies, and healthcare information technology.

The company’s Pharmaceutical Diagnostics business develops and supplies contrast media and radiopharmaceuticals used to enhance medical imaging and support the detection and monitoring of disease.